The Vanderbilt Stem Cell Transplant and Cellular Therapy Symposium offers clinicians detailed information on the latest developments for hematological diseases, ranging from immunotherapies for blood cancers to new, curative therapies for sickle cell disease.

Cathy Eng, MD, will participate in a congressional briefing on April 15 focused on “Addressing Representation in Clinical Trials.”

Chris Williams, MD, PhD, associate dean for Physician-Scientist Education and Training at Vanderbilt University, has been named to lead Research Education at Vanderbilt-Ingram Cancer Center.

Karen Winkfield, MD, PhD, Ingram Professor of Cancer Research, has been named associate director for Community Outreach and Engagement at Vanderbilt-Ingram Cancer Center.

Ongoing research by Eunyoung Choi, PhD, into how cells transform into abnormal versions of themselves that are the precursors to stomach cancer has received support from the American Association for Cancer Research.

Excessive consumption of dietary sodium likely was responsible for up to 30% of cardiovascular disease-related deaths among mostly low-income participants in a large cohort study conducted by Vanderbilt University Medical Center.

While immune checkpoint inhibitors that target the PD-1 molecule on T-cells have proven to be effective with many cancers, these immunotherapies have not worked for acute myeloid leukemia (AML), but new research has identified a “cousin” molecule as a potential therapeutic target for AML.